AP-1

AP-1
Name	AP-1 transcription factor
Family	bZIP transcription factors
Location	Nucleus
Function	Transcriptional regulation, cell proliferation, differentiation

AP-1

Activator protein 1 (AP-1) is a dimeric transcription factor complex composed of members of the JUN, FOS, ATF, and MAF protein families that regulates gene expression in response to a variety of stimuli. AP-1 integrates signals from receptor tyrosine kinases such as Epidermal growth factor receptor, cytokine receptors such as Interleukin-6 receptor, and stress-activated kinases such as Mitogen-activated protein kinase cascades to control processes including proliferation, differentiation, apoptosis, and transformation. AP-1 activity is studied in contexts ranging from developmental models like Drosophila melanogaster to human diseases investigated at institutions such as National Institutes of Health, Dana-Farber Cancer Institute, and MD Anderson Cancer Center.

Overview

AP-1 comprises dimers of basic leucine zipper proteins from the JUN family (c-JUN, JUNB, JUND), the FOS family (c-FOS, FOSB, FOSL1, FOSL2), the ATF family (ATF2, ATF3, ATF4), and small MAF proteins (MAF, MAFB), and cooperates with cofactors such as CREB-binding protein and p300 to modulate transcription at specific promoter and enhancer elements. AP-1 recognizes palindromic or related DNA motifs such as the TPA-responsive element (TRE) and cyclic AMP response element (CRE), functioning downstream of signaling pathways including Ras, Raf, MEK1/2, and ERK1/2, while cross-talking with NF-κB, STAT3, and β-catenin networks. Studies of AP-1 use biochemical methods refined in labs associated with Max Planck Society, Cold Spring Harbor Laboratory, and Howard Hughes Medical Institute.

Structure and subunits

AP-1 subunits share a basic region for DNA contact and a leucine zipper for dimerization; structures determined by X-ray crystallography and NMR by groups at European Molecular Biology Laboratory and Stanford University reveal bZIP folds similar to those in Gcn4 and cAMP response element-binding protein. c-JUN and c-FOS heterodimers display distinct DNA affinity and specificity compared to JUN homodimers or FOS-FOS interactions, with dimer composition influenced by expression regulated by transcription factors such as Myc, p53, and E2F1. The FOS proteins are immediate-early response proteins induced by stimuli like Phorbol 12-myristate 13-acetate and serum, while JUN proteins are regulated by translational and post-translational control involving enzymes studied at Salk Institute and Whitehead Institute.

DNA binding and regulatory mechanisms

AP-1 binds TRE and CRE sequences within promoters and enhancers to recruit coactivators or corepressors; cooperative binding with lineage-specific factors such as GATA1, PU.1, C/EBPα, and MEF2C establishes cell-type specific transcriptional programs. Chromatin immunoprecipitation and genome-wide assays performed at facilities like Broad Institute and Wellcome Trust Sanger Institute map AP-1 occupancy to regulatory elements enriched for histone modifications deposited by complexes including Polycomb Repressive Complex 2 and SWI/SNF, and reveal interplay with pioneer factors such as Oct4 and Sox2 in stem cell contexts. AP-1 can act as activator or repressor depending on partner choice and local chromatin state influenced by enzymes such as Histone deacetylase 1 and Histone acetyltransferase p300.

Biological functions and pathways

AP-1 controls genes governing cell cycle progression (cyclins, CDKs), apoptosis (BCL2 family), and differentiation programs in tissues including epidermis, liver, bone, and immune compartments studied using models like Mus musculus, Zebrafish, and organoids developed at Johns Hopkins University. AP-1 is required for processes downstream of growth factor signaling via the Ras-Raf-MEK-ERK and JNK pathways and mediates responses to environmental stresses such as UV radiation and oxidative stress linked to Nrf2 activity. In immune cells, AP-1 cooperates with NFAT and IRF4 to regulate cytokine gene expression during activation and is implicated in developmental pathways regulated by Notch signaling and Wnt signaling.

Regulation and post-translational modifications

AP-1 activity is regulated transcriptionally, translationally, and by post-translational modifications including phosphorylation by c-Jun N-terminal kinase and ERK2, acetylation by p300/CBP, ubiquitination by E3 ligases such as FBXW7, and SUMOylation mediated by enzymes characterized at EMBL-EBI. Phosphorylation of c-JUN at serine residues enhances transactivation, while ubiquitin-dependent degradation controls protein turnover via the proteasome pathway; cross-regulation by phosphatases such as MKP-1 and interactions with chaperones like HSP90 further fine-tune AP-1 dynamics. Signaling inputs from receptors such as Toll-like receptor 4 and Transforming growth factor beta receptor modulate AP-1 through kinases and adaptor proteins including GRB2 and SOS1.

Role in disease and clinical relevance

Dysregulated AP-1 contributes to oncogenesis in contexts including squamous cell carcinoma, hepatocellular carcinoma, and hematological malignancies analyzed by clinical centers such as Mayo Clinic and Memorial Sloan Kettering Cancer Center; AP-1-driven transcription programs promote metastasis, epithelial–mesenchymal transition, and resistance to targeted therapies such as inhibitors of EGFR and BRAF. AP-1 is implicated in inflammatory diseases and fibrosis involving pathways activated by Tumor necrosis factor and Interleukin-1, and is a target for therapeutic strategies employing small molecules, peptides, and gene therapy approaches explored in trials at National Cancer Institute and biotech firms like Amgen and Genentech. Biomarker studies correlate AP-1 component expression with prognosis and therapeutic response in datasets curated by The Cancer Genome Atlas and European Molecular Biology Laboratory–European Bioinformatics Institute.

Category:Transcription factors